These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12120207)

  • 21. Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
    Koontongkaew S; Monthanapisut P; Saensuk T
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):100-8. PubMed ID: 20654727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
    Hayashi T; Nishiyama K; Shirahama T
    Int J Urol; 2006 Aug; 13(8):1086-91. PubMed ID: 16903934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoxygenase inhibitors for the treatment of pancreatic cancer.
    Kennedy TJ; Chan CY; Ding XZ; Adrian TE
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):525-36. PubMed ID: 12934664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eicosanoid regulation of angiogenesis in tumors.
    Nie D; Honn KV
    Semin Thromb Hemost; 2004 Feb; 30(1):119-25. PubMed ID: 15034803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoxygenase modulation to reverse carcinogenesis.
    Shureiqi I; Lippman SM
    Cancer Res; 2001 Sep; 61(17):6307-12. PubMed ID: 11522616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor.
    Yoshimura R; Inoue K; Kawahito Y; Mitsuhashi M; Tsuchida K; Matsuyama M; Sano H; Nakatani T
    Int J Mol Med; 2004 Jan; 13(1):41-6. PubMed ID: 14654968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of cyclooxygenases and lipoxygenases in renal ischemia-reperfusion injury.
    Matsuyama M; Nakatani T; Hase T; Kawahito Y; Sano H; Kawamura M; Yoshimura R
    Transplant Proc; 2004 Sep; 36(7):1939-42. PubMed ID: 15518705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival.
    Tang DG; Honn KV
    J Cell Physiol; 1997 Aug; 172(2):155-70. PubMed ID: 9258337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention.
    Cuendet M; Pezzuto JM
    Drug Metabol Drug Interact; 2000; 17(1-4):109-57. PubMed ID: 11201293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
    Tucker ON; Dannenberg AJ; Yang EK; Zhang F; Teng L; Daly JM; Soslow RA; Masferrer JL; Woerner BM; Koki AT; Fahey TJ
    Cancer Res; 1999 Mar; 59(5):987-90. PubMed ID: 10070951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.
    Knab LM; Grippo PJ; Bentrem DJ
    World J Gastroenterol; 2014 Aug; 20(31):10729-39. PubMed ID: 25152576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.
    Hennig R; Grippo P; Ding XZ; Rao SM; Buchler MW; Friess H; Talamonti MS; Bell RH; Adrian TE
    Cancer Res; 2005 Jul; 65(14):6011-6. PubMed ID: 16024599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase as a new target for pancreatic cancer treatment.
    Sato N; Mizumoto K; Nagai E; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer.
    Ding XZ; Hennig R; Adrian TE
    Mol Cancer; 2003 Jan; 2():10. PubMed ID: 12575899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer.
    Albazaz R; Verbeke CS; Rahman SH; McMahon MJ
    Pancreatology; 2005; 5(4-5):361-9. PubMed ID: 15980665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between lipoxygenase and human testicular cancer.
    Yoshimura R; Matsuyama M; Mitsuhashi M; Takemoto Y; Tsuchida K; Kawahito Y; Sano H; Nakatani T
    Int J Mol Med; 2004 Mar; 13(3):389-93. PubMed ID: 14767568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targeting therapy for pancreatic cancer.
    Xiong HQ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S69-77. PubMed ID: 15316751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
    Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
    Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.